TL1A：TL1A as a therapeutic target in inflammatory bowel disease
TL1A as a therapeutic target in inflammatory bowel disease
由GKokkotis著作·2022·被引用9次—Inconclusion,targetingofTL1A/DR3signalingmayproveanefficientwaytoameliorateintestinalandsystemicinflammationinpatientswithIBD.Nevertheless, ...。其他文章還包含有：「RoleofTL1AinInflammatoryAutoimmuneDiseases」、「TL1Ainhibitionforinflammatoryboweldiseasetreatment」、「Astable」、「RoleofTL1AanditsreceptorDR3intwomodelsofchronic...」、「TL1AInhibitorsCouldUsherinN...
查看更多 離開網站
Role of TL1A in Inflammatory Autoimmune Diseases
https://www.ncbi.nlm.nih.gov
TL1A, also called TNFSF15, is a member of tumor necrosis factor family. It is expressed in different immune cell, such as monocyte, ...
TL1A inhibition for inflammatory bowel disease treatment
https://www.sciencedirect.com
The pivotal role of TL1A in modulating immune pathways crucial for inflammatory bowel disease (IBD) and intestinal fibrosis offers a ...
A stable
https://www.nature.com
TL1A (TNFSF15) is a TNF superfamily ligand which can bind the TNFRSF member death receptor 3 (DR3) on T cells and the soluble decoy receptor ...
Role of TL1A and its receptor DR3 in two models of chronic ...
https://www.pnas.org
TL1A is a TNF-like cytokine that binds to the death-domain receptor (DR)3 and provides costimulatory signals to activated lymphocytes.
TL1A Inhibitors Could Usher in New Era for IBD Treatment
https://www.biospace.com
TL1A (tumor necrosis factor-like cytokine 1A) is part of the tumor necrosis factor (TNF) superfamily, a group of cell-signaling molecules that ...